Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: In a report released Wednesday, the experts said annual cases of Legionnaires’ jumped more than fivefold from 2000 to 2017, and that as many as 70,000 Americans get the disease every year. Legionnaires’ is caused by bacteria that can thrive in buildings with large water systems. About 20 outbreaks are reported each year, including recent ones at an Atlanta hotel and a hospital near Chicago. But there is no single set of widely accepted guidelines for preventing infections. The National Academies of Sciences, Engineering and Medicine report pushes for requirements like minimum temperature levels for hot-water heaters, and registration and monitoring of cooling towers.
[A]: Experts call for steps to stem increases in Legionnaires’.


[Q]: The study tracked about 20,000 severely obese patients with Type 2 diabetes. Those who had weight loss surgery had a 40 percent lower chance of developing a heart attack or stroke in the five years following surgery compared to those who got usual care with diabetes medicines or insulin. For every 1,000 patients in the study who had surgery there were roughly 20 heart attacks or strokes compared to 40 such events per 1,000 who got regular care. More than 30 million Americans have diabetes, mostly Type 2 where the body loses the ability to produce or use insulin to turn food into energy. Other research has shown obesity surgery can reverse and even prevent diabetes. Taken together, it means doctors should discuss weight loss surgery more often, said study co-author Dr. David Arterburn of Kaiser Permanente Washington Health Research Institute in Seattle. Doctors usually mention insulin and pills, “but it’s not always brought up that weight loss surgery is another available treatment option,” Arterburn said. Researchers analyzed records from four U.S. health care systems: HealthPartners in Minnesota and Kaiser Permanente in Washington state, Northern California and Southern California. Results were published Tuesday in the Journal of the American Medical Association. The study can’t prove cause and effect because patients weren’t randomly assigned to get surgery. The researchers tried to match patients for gender, age, blood sugar levels and other factors. But other things they didn’t account for could have contributed to the surgery patients’ better results. Everyone in the study had a BMI, or body mass index, of at least 35. For instance, someone who is 5-foot-8-inches and weighs 230 pounds has a BMI of 35. Of the more than 5,300 who had surgery, most had gastric bypass, the most common type of stomach-shrinking operation. Some had gastric sleeve or gastric band procedures. The rest, nearly 15,000 people, had usual care. Obesity surgery can cost $20,000 to $25,000. Insurers are increasingly covering it, but some impose strict limits. The new findings suggest insurance coverage should be expanded for the right patients, Dr. Sayeed Ikramuddin of the University of Minnesota wrote in an accompanying editorial. Surgery is thought to help by affecting hormones, gut bacteria and other substances that affect how the body handles insulin and blood sugar. Weight loss without surgery also helps, but is difficult for many people to achieve. Most weight loss surgery today is done through small incisions. The dangers are similar to other surgeries, including a small chance of life-threatening complications, and some people need to have their surgeries repeated. ___ Follow AP Medical Writer Carla K. Johnson on Twitter: @CarlaKJohnson ___ The Associated Press Health &amp; Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
[A]: Obesity surgery may lower heart attack danger in diabetics.


[Q]: But months later, when her daughter saw a TV ad for a law firm asking ovarian cancer victims who used talcum powder to come forward, Giannecchini realized a possible link: She had been using Johnson & Johnson’s baby powder for most of her life. “I used it for 45 years, from age 15,” Giannecchini, now 63, said Friday. “I was still using it.” On Thursday, a St. Louis jury awarded more than $70 million to Giannecchini, of Modesto, California, wrapping up a monthlong trial. It was the third big verdict awarded by a St. Louis jury against Johnson & Johnson in ovarian cancer lawsuits this year. Combined, the three awards amount to nearly $200 million. Giannecchini said she was happy with the verdict, but it doesn’t make up for the cancer fight and ongoing health problems caused by chemotherapy. “There’s not enough money in the world to pay for fighting the cancer,” she said at a news conference arranged by her lawyers. A spokeswoman for Johnson & Johnson said in a statement that while the company sympathizes with women and their families impacted by ovarian cancer, it will appeal the latest verdict “because we are guided by the science, which supports the safety of Johnson’s Baby Powder.” About 2,000 women nationwide have filed similar suits over concerns about health damage caused by extended talcum powder use. Lawyers are reviewing many additional cases, many of them generated by television ads by law firms. In February, a St. Louis jury awarded $72 million to relatives of an Alabama woman who died of ovarian cancer. Another jury awarded $55 million in May to a South Dakota survivor of the disease. But two cases in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer, an often fatal but relatively rare form of cancer. Ovarian cancer accounts for about 22,000 of the 1.7 million new cases of cancer expected to be diagnosed in the U.S. this year. Factors known to increase a women’s risk of ovarian cancer include age, obesity, use of estrogen therapy after menopause, not having any children, certain genetic mutations and personal or family history of breast or ovarian cancer. Talc is a mineral that is mined from deposits around the world, including the U.S. The softest of minerals, it’s crushed into a white powder. It’s been widely used in cosmetics and other personal care products to absorb moisture since at least 1894, when Johnson & Johnson’s baby powder was launched. But it’s mainly used in a variety of other products, including paint and plastics. Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless. Still, the International Agency for Research on Cancer classifies genital use of talc as “possibly carcinogenic.” Attorneys with Onder, Shelton, O’Leary & Peterson, the firm that handled all three St. Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s. They cite case studies showing that women who regularly use talc on their genital area face up to a 40 percent higher risk of developing ovarian cancer. The firm has also accused Johnson & Johnson of marketing toward overweight women, blacks and Hispanics — the very same women most at-risk for ovarian cancer. Wylie Blair, an attorney for Giannecchini, said the firm is working with about 1,700 additional plaintiffs. Another trial is scheduled for February. Blair said there has been no talk with Johnson & Johnson concerning a class-action settlement. “Acknowledging that a seminal product that everybody identifies with the company has been causing a horrible disease for all these years is going to be a tough pill to swallow for them,” Blair said. Giannecchini said that as of now there is no evidence of cancer, but she won’t know for years if she is free of the disease. “One day at a time,” she said. “Just stay hopeful.”
[A]:
Talc verdict winner: Money can’t make up for lost health.